$HUBS

HUBSPOT INC

AlphAI earnings readsecond quarter 2026 · AUG 5HubSpot Reports Q2 2026 ResultsVerdict: solid

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

1
3
0
—
$2.0M
Halligan Brian
100%
See all $HUBS insider activity →
Low

Why HubSpot Stock Rallied Today

HubSpot (HUBS) stock rose 6.1% on Thursday amid speculation about potential mergers and acquisitions in the software sector. Recent deals, including Salesforce's $5.66B acquisition of Braze, have sparked discussions about further consolidation. Analysts suggest HubSpot could be a target, though it's seen as unlikely. The company has a market cap of over $13B.

HubSpot director Brian Halligan sells $2.04 million in shares

HubSpot director Brian Halligan sold 8,500 shares for $2.04 million at $239.57 per share on October 20, 2026, under a 10b5-1 plan. He holds 353,654 shares directly and 59,500 indirectly. HubSpot stock is down 38% YTD but trades at $249.90, with a market cap of $12.5 billion and P/E ratio of 89.25. The company announced a 7% workforce reduction, expecting $65M-$75M in charges. Analysts have mixed ratings, with targets ranging from $250 to $300.

HUBS sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 4 news stories mentioning HUBS (HUBSPOT INC). Coverage has skewed bullish: 1 bullish, 3 neutral, and 0 bearish.

Recent HUBS coverage spans financial news, market movers and insider activity.

In the last 30 days, HUBS insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($2.0M). The most active reporter was Halligan Brian with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving HUBS

AlphAI scores every news story that mentions HUBS with an AI model for sentiment and relevance, and aggregates insider trades from HUBSPOT INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $HUBS

Score

Why HubSpot Stock Rallied Today

HubSpot (HUBS) stock rose 6.1% on Thursday amid speculation about potential mergers and acquisitions in the software sector. Recent deals, including Salesforce's $5.66B acquisition of Braze, have sparked discussions about further consolidation. Analysts suggest HubSpot could be a target, though it's seen as unlikely. The company has a market cap of over $13B.

$HUBSLow

HubSpot director Brian Halligan sells $2.04 million in shares

HubSpot director Brian Halligan sold 8,500 shares for $2.04 million at $239.57 per share on October 20, 2026, under a 10b5-1 plan. He holds 353,654 shares directly and 59,500 indirectly. HubSpot stock is down 38% YTD but trades at $249.90, with a market cap of $12.5 billion and P/E ratio of 89.25. The company announced a 7% workforce reduction, expecting $65M-$75M in charges. Analysts have mixed ratings, with targets ranging from $250 to $300.

$HUBSLow

CRM Vendors Tackle AI Costs and Customer Data Access

CRM vendors HubSpot, Salesforce, and Adobe are enhancing AI capabilities. HubSpot introduced flexible pricing to manage AI costs. Salesforce partnered with Demandbase for real-time sales prospecting data. Adobe added AI journey analytics and data access controls. Other companies like Accenture, VeriPark, and Revinate are also improving customer data integration.

Notable analyst calls: Salesforce, Walmart and Lockheed Martin gain analyst support as tech downgrades mount

Bank of America upgraded Salesforce (CRM) to Buy, raising its price target to $285, citing AI adoption and strong free cash flow. Barclays downgraded Dell (DELL), HPE (HPE), NetApp (NTAP), HubSpot (HUBS), and monday.com (MNDY) due to AI growth concerns. Deutsche Bank upgraded Walmart (WMT) to Buy, targeting $136, citing inflation benefits. RBC downgraded GoDaddy (GDDY) to Sector Perform, citing AI's impact. MongoDB (MDB) ratings reaffirmed by Needham and BofA.

Salesforce upgraded, Adobe downgraded: Wall Street's top analyst calls

BofA upgraded Salesforce (CRM) to Buy with a $285 target, citing enterprise platform resilience. Raymond James upgraded Humana (HUM) to Outperform with a $520 target, noting Medicare Advantage growth. T-Mobile (TMUS) also upgraded to Outperform with a $170 target. Truist upgraded First Solar (FSLR) to Buy with a $270 target. JPMorgan upgraded Biogen (BIIB) to Overweight with a $300 target. Wells Fargo double-downgraded Adobe (ADBE) to Underweight with a $225 target.

Related tickers